6/3/2008

Cognate BioServices will build a manufacturing facility in Israel to expand its client reach, a representative of Cognate's lead investor said. Potential Israeli customers for the U.S.-based stem cell firm include Gamida Cell, Pluristem Therapeutics and Brainstorm Cell Therapeutics.

Full Story:
Globes (Israel)

Related Summaries